Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05709873 · ClinicalTrials.gov registry record · NA
Narcolepsy Nightmare Study
A NA study of Narcolepsy and Narcolepsy Type 1, sponsored by Northwestern University.
- Completed
- Registry status
- NA
- Development phase
- 7
- Enrollment target
- 1
- Study location
NCT05709873: Completed NA study of Narcolepsy and Narcolepsy Type 1, sponsored by Northwestern University.
NCT05709873 is a NA study of Narcolepsy and Narcolepsy Type 1 that has completed, run by Northwestern University. The registered enrollment target is 7 participants, below the 380-participant average among 12 other Narcolepsy trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05709873, a NA study of Narcolepsy and Narcolepsy Type 1, has completed, sponsored by Northwestern University.
- COMPLETED
- Registry status
- NA
- Development phase
- 7 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this clinical trial is to test two behavioral treatments for nightmares in adults with narcolepsy. The main questions it aims to answer are: * Is imagery rehearsal therapy (IRT) effective for narcolepsy-related nightmares? * Does adding targeted dream control (TDC) to IRT make it more effective? Participants will be randomized to one of two treatment groups and will be asked to: * Complete a daily log of sleep symptoms for up to 13 weeks. * Attend 7 sessions of treatment. * Complete questionnaires before and after treatment. * Go to the research lab in Evanston, IL to complete a sleep study during a daytime nap (Chicago area residents only).
Primary Outcome
Frequency of nightmares as measured by daily diary
Conditions Studied
Interventions
- BEHAVIORAL Imagery rehearsal therapy
- BEHAVIORAL Targeted dream control
Study Locations (1)
Illinois
- Northwestern University - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2023-02-22 |
| Est. Completion | 2024-04-30 |
| Phase | NA |
What the finished NCT05709873 record still lists
NCT05709873 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 7 participants, a relatively small participant target, below the 380-participant average among 12 other Narcolepsy trials with a reported enrollment target (98% lower).
The record links to 5 conditions, with Narcolepsy appearing as the primary indexed condition, and to 2 interventions - of which Imagery rehearsal therapy is the first listed.
NCT05709873 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT05709873 about?
NCT05709873 is a clinical study titled "Narcolepsy Nightmare Study". The goal of this clinical trial is to test two behavioral treatments for nightmares in adults with narcolepsy. The main questions it aims to answer are: * Is imagery rehearsal therapy (IRT) effective for narcolepsy-related nightmares? * Does adding targeted dream control (TDC) to IRT make it more e...
What is the current status of trial NCT05709873?
This trial is currently completed. It is a NA study. The enrollment target is 7 participants. The study started on 2023-02-22. Estimated completion is 2024-04-30.
What conditions does trial NCT05709873 study?
This clinical trial studies the following conditions: Narcolepsy, Narcolepsy Type 1, Narcolepsy Type 2, Narcolepsy With Cataplexy, Narcolepsy Without Cataplexy.
What interventions are being tested in trial NCT05709873?
The interventions under investigation include: Imagery rehearsal therapy (BEHAVIORAL), Targeted dream control (BEHAVIORAL).
Who is sponsoring clinical trial NCT05709873?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05709873 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Narcolepsy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05709873's enrollment target sits among peer trials
7 13th of 12 the lowest of 12 other Narcolepsy trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Narcolepsy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Psychosocial Adjunctive Treatment for Hypersomnia (PATH)
COMPLETED · NA
-
SUNOSI® (Solriamfetol) Pregnancy Registry
RECRUITING
-
A Study to Investigate Efficacy, Safety, Tolerability, and Pharmacokinetics of JZP441 Compared With Placebo in Participants With Narcolepsy Type 1
RECRUITING · Phase 1
-
Child and Adolescent Registry for Participants With Narcolepsy
RECRUITING
-
WAKIX® (Pitolisant) Pregnancy Registry
RECRUITING
-
A Study of the Safety and Effectiveness of ADX-N05 for Excessive Daytime Sleepiness in Subjects With Narcolepsy
COMPLETED · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI